Observational Study
Copyright ©The Author(s) 2017.
World J Radiol. Jun 28, 2017; 9(6): 287-294
Published online Jun 28, 2017. doi: 10.4329/wjr.v9.i6.287
Table 1 Patient characteristics for the three risk categories1
Low risk (n = 16)Intermediate risk (n = 34)High risk (n = 5)
General
Male/female5/11 (31%/69%)16/18 (47%/53%)0/5 (0%/100%)
Age (yr)239.5 ± 13.450.7 ± 12.5a42.4 ± 15.8
Educational level35 (range 2-6)5 (range 2-7)5 (range 4-6)
Epilepsy-related
Symptomatic/non-symptomatic epilepsy2/14 (13/88%)15/19 (44/56%)0/5
Seizure frequency
Weekly01 (3%)0
Monthly4 (25%)3 (9%)0
Yearly2 (13%)6 (18%)2 (40%)
Seizure free10 (63%)24 (71%)3 (60%)
Years since epilepsy onset222.7 ± 11.730.4 ± 13.426.8 ± 23.3
Epilepsy severity score21.4 ± 0.81.2 ± 1.01.0 ± 0.7
AED-related
Mono-/polytherapy16/08/26 (24/77%)a3/2 (60/40%)b
Medication type
CBZ017 (50%)1 (20%)
LEV7 (44%)6 (18%)0
LTG9 (56%)10 (29%)1 (20%)
OXC04 (12%)0
PHT016 (47%)0
TPM005 (100%)
VPA07 (21%)1 (20%)
Drug load2,41.3 ± 0.61.8 ± 0.7a1.2 ± 1.0
Table 2 Results of the neuropsychological investigation, represented as mean ± SD for each risk category
Cognitive test results
CVST (s)1Raven2
Risk category
Low risk11.5 ± 2.971.7% ± 10.3%
Intermediate risk15.7 ± 6.473.2% ± 10.1%
High risk20.2 ± 6.771.7% ± 3.1%
P value30.0080.85